PANCREATICOSPLENECTOMY

This adverse event was reported 13 times

These drugs are most commonly taken by patients reporting PANCREATICOSPLENECTOMY:

# Drug Count
0 PANCRELIPASE 4
1 INTERFERON BETA-1A 2
2 PEMBROLIZUMAB 2
3 ANASTROZOLE 1
4 DIAZOXIDE 1
5 DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE 1
6 EMPAGLIFLOZIN 1
7 FLUVASTATIN 1
8 INSULIN GLARGINE 1
9 INSULIN HUMAN 1
See all common drugs associated with PANCREATICOSPLENECTOMY

PANCREATICOSPLENECTOMY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DIAZOXIDE 1 0.0014
1 DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE 1 0.0001
2 PANCRELIPASE 4 0.0001
3 VALPROATE SODIUM 1 0.0000
4 SITAGLIPTIN AND METFORMIN HYDROCHLORIDE 1 0.0000
5 LENVATINIB 1 0.0000
6 ANASTROZOLE 1 0.0000
7 INSULIN HUMAN 1 0.0000
8 PEMBROLIZUMAB 2 0.0000
9 EMPAGLIFLOZIN 1 0.0000
See all drugs enriched for association with PANCREATICOSPLENECTOMY

PANCREATICOSPLENECTOMY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Insulin [EPC] 1 0.0000
1 Programmed Death Receptor-1 Blocking Antibody [EPC] 2 0.0000
2 Interferon beta [EPC] 2 0.0000
3 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1 0.0000
4 Aromatase Inhibitor [EPC] 1 0.0000
5 Insulin Analog [EPC] 2 0.0000
6 Kinase Inhibitor [EPC] 1 0.0000
See all drug classes enriched for association with PANCREATICOSPLENECTOMY